AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Colgate-Palmolive: JP Morgan maintains a 'Overweight' Rating, The Target Price is $95
ByAinvest
Monday, Aug 4, 2025 12:00 pm ET1min read
JP Morgan maintains 'Overweight' rating on Colgate-Palmolive(CL).
The target price is $95, compare with $99 previously.
[Recent Rating]
| Date | Agency | Change | Rating | Rating （previously） | Target Price | Target Price（previously） |
|---|---|---|---|---|---|---|
| 2025-08-04 | Citigroup | Maintains | Buy | Buy | $105 | $108 |
| 2025-08-04 | Morgan Stanley | Maintains | Overweight | Overweight | $96 | $104 |
| 2025-08-04 | JP Morgan | Maintains | Overweight | Overweight | $95 | $99 |
| 2025-07-25 | JP Morgan | Maintains | Overweight | Overweight | $99 | $103 |
| 2025-07-17 | UBS | Maintains | Buy | Buy | $106 | $109 |
| 2025-07-15 | Barclays | Maintains | Equal-Weight | Equal-Weight | $87 | $86 |
[Recent Earning Results] Colgate-Palmolive posted the Q2 of its 2025 financial results on 8/1/2025, reporting total revenue of USD 10021.00 million in the first half of the year, down 1.02% from USD 10124.00 million year over year, reporting net income of USD 1499.00 million in the first half of the year, up 0.27% from USD 1495.00 million year over year.
[Company Profile] Colgate-Palmolive Company is a leading consumer products company whose products are marketed in over 200 countries and territories throughout the world. Colgate was founded in 1806 and incorporated under the laws of the State of Delaware in 1923. The company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Colgate is a leader in many product categories of the Personal Care market with global leadership in liquid hand soap, which it sells under the Softsoap, Palmolive and Protex brands according to market share data.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet